Skip to search formSkip to main contentSkip to account menu

bopindolol

Known as: 1-(tert-butylamino)-3-((2-methylindo)-4-yl)-2-propanol benzoate, 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((2-methyl-1H-indol-4-yl)oxy)-, benzoate (ester), (+-)- 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Adrenergic beta-AntagonistsPindolol

Narrower (1)

Sandonorm
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis.
1998
1998
Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
The aim of this study was to test the hypothesis that prolonged treatment of mild to moderate hypertension with low-dose thiazide… 
1994
1994
Changes in physical symptoms, blood pressure and quality of life over 30 days.
1991
1991
Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
Using a radioligand binding assay, we assessed the affinity and selectivity of the antagonistic effects of bopindolol (4… 
1990
1990
Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
1. The effect of withdrawal of atenolol and bopindolol administration was studied in 12 normal volunteers; six on each drug. 2… 
1988
1988
Certain beta-blockers can decrease beta-adrenergic receptor number: I. Acute reduction in receptor number by tertatolol and bopindolol.
We have previously reported that a potent new beta-blocker, tertatolol, when given at therapeutic doses to healthy volunteers… 
1988
1988
Cardiovascular effects of apamin and BRL 34915 in rats and rabbits
1 The cardiovascular effects of apamin, a selective blocker of certain calcium‐activated potassium channels, and BRL 34915, a… 
1986
1986
Plasma lipid fractions during bopindolol treatment in hypertensive patients.
The influence of bopindolol monotherapy on blood pressure and plasma lipid fractions was investigated in 24 hypertensive patients… 
1985
1985
Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
Bopindolol is a potent and specific beta-adrenoceptor antagonist with partial agonist activity. In animal experiments it blocks… 
1984
1984
Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.
The influence of bopindolol monotherapy on blood pressure and plasma lipid fractions was investigated in 24 hypertensive patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)